1. Professor John M. Goldman, CML Pioneer 1938–2013

   • Robert Peter Gale

   Obituary 12 January 2014 Pages: 103 - 104

2. Guest editorial: immunotherapy for hematological malignancies: the quest to overcome tolerogenic drive

   • Norimitsu Kadowaki

   Progress in Hematology 07 January 2014 Pages: 105 - 106

3. Peptide vaccines for hematological malignancies: a missed promise?

   • Monica Bocchia
   • Marzia Defina
   • Anna Sicuranza

   Progress in Hematology 08 January 2014 Pages: 107 - 116

   

4. DC-based immunotherapy for hematological malignancies

   • Toshio Kitawaki

   Progress in Hematology 31 December 2013 Pages: 117 - 122

   

5. Adoptive T-cell therapy for hematological malignancies using T cells gene-modified to express tumor antigen-specific receptors

   • Hiroshi Fujiwara

   Progress in Hematology 19 December 2013 Pages: 123 - 131

   

6. Chimeric antigen receptor modified T cell therapy for B cell malignancies

   • Cameron J. Turtle

   Progress in Hematology 14 December 2013 Pages: 132 - 140

   

7. Efficacy and safety of dasatinib versus imatinib in Japanese patients with newly diagnosed chronic-phase chronic myeloid leukemia (CML-CP): Subset analysis of the DASISION trial with 2-year follow-up

   • Shin Fujisawa
   • Hirohisa Nakamae
   • Shintaro Onishi

   Original Article 20 December 2013 Pages: 141 - 153

   

8. Liver disease is frequently observed in Down syndrome patients with transient abnormal myelopoiesis

   • Myoung Ja Park
   • Manabu Sotomatsu
   • Yasuhide Hayashi

   Original Article 14 December 2013 Pages: 154 - 161

   

9. Impact of high-dose chemotherapy and autologous transplantation as first-line therapy on the survival of high-risk diffuse large B cell lymphoma patients: a single-center study in Japan

   • Shojiro Inano
   • Makoto Iwasaki
   • Nobuyoshi Arima

   Original Article 14 December 2013 Pages: 162 - 168

   

10. RUNX1 mutation associated with clonal evolution in relapsed pediatric acute myeloid leukemia with t(16;21)(p11;q22)

    • Olfat Ismael
    • Akira Shimada
    • Seiji Kojima

    Original Article 28 December 2013 Pages: 169 - 174

    

11. ACE deletion polymorphism is associated with a high risk of non-infectious pulmonary complications after stem cell transplantation

    • Mitsuki Miyamoto
    • Makoto Onizuka
    • Kiyoshi Ando

    Original Article 21 December 2013 Pages: 175 - 183

    

12. De novo mutation in DMD gene in a patient with combined hemophilia A and Duchenne muscular dystrophy

    • Lana Strmecki
    • Petra Hudler
    • Radovan Komel

    Case Report 08 December 2013 Pages: 184 - 187

    

13. Thalidomide treatment in a myelofibrosis patient with leukemia transformation

    • Wei-Han Huang
    • Ming-Shing Li
    • Yi-Feng Wu

    Case Report 04 December 2013 Pages: 188 - 192

    

14. Successful repeated treatment of acute myeloid leukemia in early relapse with gemtuzumab ozogamicin alone

    • Hiroko Tsunemine
    • Hiroshi Akasaka
    • Takayuki Takahashi

    Case Report 01 December 2013 Pages: 193 - 197

    

15. MALT lymphoma of the small bowel with protein-losing enteropathy

    • Ayato Tsukamoto
    • Fumihiko Nakamura
    • Mineo Kurokawa

    Case Report 07 January 2014 Pages: 198 - 201

    

16. inv(2)(p23q13)/RAN-binding protein 2 (RANBP2)–ALK fusion gene in myeloid leukemia that developed in an elderly woman

    • Yoshitomo Maesako
    • Kiyotaka Izumi
    • Hitoshi Ohno

    Case Report 04 December 2013 Pages: 202 - 207

    

17. Different outcomes of allogeneic hematopoietic stem cell transplant in a pair of twins affected by juvenile myelomonocytic leukemia

    • Simone Cesaro
    • Paola De Filippi
    • Silvia Bresolin

    Case Report 12 December 2013 Pages: 208 - 212